CAS: 741709-63-7; 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Picolinonitrile

该化合物是一种化学化合物,其特点是其独特的结构,包括一个硅蛋白激素和含有二氧新罗内烷的共聚物组;二氧新郎环的存在有助于其在有机合成和材料科学中的潜在应用,特别是在开发基于黄柱的试剂和催化剂方面.分子的皮蛋白分泌部分提供了一个硝化物功能组,以其活性及参与各种化学变异的能力而闻名.这种复合物可能显示出诸如有机溶剂中的溶性,某些条件下的稳定性以及由于有硝酸三烯组物的存在而可能具有的核分裂性等特性.其具体应用范围可能包括药用化学到新材料的开发,取决于其反应性和与金属或其他子质形成复合体的能力.

结构式图片

相似化合物

1011722-07-8 1257553-74-4 1073354-14-9

欧盟法规

C&L通报

上下游产品

2-Cyano-5-bromopyridine bis(pinacol)diborane 5-bromo-pyridine-2-carbaldehyde C-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-methylamineC-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-methylamine tert-butyl 4-((5-(6-cyanopyridin-3-yl)-2-methoxybenzyloxy)methyl)-4-phenylpiperidine-1-carboxylate 5-(2-formylphenyl)pyridine-2-carbonitrile 5-[6-(3,4-dimethoxy-phenyl)-2-methyl-imidazo[1,2-b]pyridazin-3-yl]-[2,3']bipyridinyl-6'-carbonitrile

合成工艺路线路线简述

    5-溴-2-吡啶甲醛置于(1,1'-Bis(Diphenylphosphino)Ferrocene)Palladium(II) Dichloride,Ammonium Hydroxide,碘,Potassium Acetate体系中,用 四氢呋喃,二甲基亚砜 作为反应溶剂,化学反应 29.0H,反应生成 2-氰基吡啶-5-硼酸频那酯
    参考文献:Biological Evaluation Of Isothiazoloquinolones Containing Aromatic Heterocycles At The 7-Position: In Vitro Activity Of A Series Of Potent Antibacterial Agents That Are Effective Against Methicillin-Resistant Staphylococcus Aureus
    标题:Biological Evaluation Of Isothiazoloquinolones Containing Aromatic Heterocycles At The 7-Position: In Vitro Activity Of A Series Of Potent Antibacterial Agents That Are Effective Against Methicillin-Resistant Staphylococcus Aureus
    摘要:We Synthesized A Diverse Series Of 9H-Isothiazolo[5,4-B]Quinoline-3,4-Diones Containing Heteroaromatic Groups At The 7-Position Via Palladium-Catalyzed Cross-Coupling. Many Of These Compounds Demonstrated Potent Antistaphylococcal Activity (Mics <= 2 Mu G/ml) Against A Multi-Drug-Resistant Strain (Atcc 700699) And Low Cytotoxic Activity (Cc50 > 100 Mu M) Against The Human Cell Line Hep2 (Laryngeal Carcinoma). (C) 2005 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Bmcl.2005.11.064

    海关参考信息

    专利信息


    专利号:WO-2023141114-A2
    优先权日:2022-01-18
    标 题:Synthesis of boron-containing amidoxime reagents and their application to synthesize functionalized oxadiazole and quinazolinone derivatives

    专利号:WO-2024159285-A1
    优先权日:2023-01-30
    标题 :Nav1.7- and/or nav1.8-inhibiting aryl pyridine compounds, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
    发明人:BARREIRO GABRIELA; SANT’ANA DANILO PEREIRA DE; MONTEIRO JÚLIA LAMMOGLIA; GAMBA LUIS EDUARDO REINA; LIMA LÃ?DIA MOREIRA; FRAGA CARLOS ALBERTO MANSSOUR; BARREIRO ELIEZER JESUS DE LACERDA
    权利人:EUROFARMA LABORATORIOS S A; UNIV FEDERAL DO RIO DE JANEIRO – UFRJ
    摘要:The present invention relates to Nav1.7- and/or Nav1.8-inhibiting aryl pyridine compounds. More specifically, the present invention relates to aryl pyridines comprising formula (I): (I), in which the substituents R1 to R10 are selected independently of the groups defined in the description, as well as to processes for preparing same, compositions comprising at least one of these compounds, uses, treatment methods for treating or preventing pain-related pathologies, and kits. The present invention pertains to the fields of medicinal chemistry and organic synthesis, as well as to the treatment of pain-related diseases.
    北京偶合科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ouhechem.com
    企业联系电话:010-51280831(不占线);010-82967028👤
    📞北京偶合科技有限公司 ⚠️参考联系方式
    联系人:刘先生
    电话:010-51280831(不占线);010-82967028
    手机:13911808554
    传真:010-82967029
    邮箱:sales@ouhechem.com
    通信地址: 北京市海淀区西三旗桥东上奥世纪2b-1328室
    邮编: 100096
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三旗桥东上奥世纪2b-1328室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1021/jm400508e
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知